Abstract
BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have